Buy KOSELUGO 25 mg/1 SELUMETINIB

Koselugo 25 mg capsules are a medication used to manage specific conditions. This oral treatment is designed for precise therapeutic use, offering a targeted approach to symptom management.

Strength

25 mg/1

Pack Size

60 CAPSULE in 1 BOTTLE (0310-0625-60)

Manufacturer / TM Owner

AstraZeneca Pharmaceuticals LP

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Koselugo 25 mg capsules are primarily used for the treatment of certain genetic disorders. This medication is often prescribed to address symptoms associated with these conditions, providing relief and improving quality of life. What is Koselugo used for? It is typically utilized in cases where other treatments have proven ineffective or where a targeted therapy is required.

Side Effects

Common effects of Koselugo 25 mg capsules may include gastrointestinal issues, fatigue, and skin-related side effects. These effects can vary in severity and duration, depending on individual patient factors. It is important to monitor for any adverse reactions and consult a healthcare provider if concerns arise.

Precautions & Warnings

Koselugo 25 mg capsules should be handled with care, following the prescribed dosage and administration guidelines. Patients should avoid activities that require alertness if they experience drowsiness. Regular monitoring and follow-up with a healthcare provider are recommended to ensure safe and effective use.

Avoid Interactions

Koselugo 25 mg capsules may interact with certain medications, including those metabolized by the liver. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances that affect liver function should be used with caution.

References

Frequently Asked Questions

Koselugo is used to treat specific genetic disorders, often when other treatments have not been effective.

Koselugo capsules are taken orally, typically following the dosage instructions provided by a healthcare professional.

Common side effects may include gastrointestinal issues, fatigue, and skin-related effects.

Koselugo may interact with certain medications, so it is important to consult a healthcare provider before combining treatments.

Koselugo should be stored at room temperature, away from moisture and heat, and kept out of reach of children.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.